Memphasys Ltd

IG7

Company Profile

  • Business description

    Memphasys Ltd is an Australian reproductive biotechnology company developing and commercializing novel reproduction and fertility solutions for humans and animals. The products in its development pipeline include a range of devices, media, and in vitro diagnostic solutions. The company is currently focused on the commercialisation of its patented Felix System, a novel bio-separation technology for assisted reproduction, designed to revolutionise sperm separation in assisted reproductive technology (ART) by providing a rapid, gentle, and automated process. The group has only one operating segment, being Reproductive Technologies, the assets and liabilities of which are located in Australia.

  • Contact

    34-36 Richmond Road
    Level 1
    Homebush West
    SydneyNSW2140
    AUS

    T: +61 284157300

    https://www.memphasys.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2026

    Employees

    28

Stocks News & Analysis

stocks

Undervalued ASX listed payment provider

Strong start to the new fiscal year.
stocks

Overpriced ASX listed consumer electronics retailers

Solid balance sheets, lower business risk and strong sales but investors are overly optimistic.
stocks

Nvidia and AMD: Maintain fair value estimate amid reports of Meta’s negotiations to buy Google TPUs

Our update on select stocks from the Semiconductors industry.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,918.7027.800.31%
CAC 408,122.7123.240.29%
DAX 4023,836.7968.830.29%
Dow JONES (US)47,716.42289.300.61%
FTSE 1009,720.5126.580.27%
HKSE25,858.8987.04-0.34%
NASDAQ23,365.69151.000.65%
Nikkei 22550,253.9186.810.17%
NZX 50 Index13,489.1556.950.42%
S&P 5006,849.0936.480.54%
S&P/ASX 2008,614.1022.300.26%
SSE Composite Index3,888.6013.340.34%

Market Movers